Tag: parathyroid hormone market size

  • Key Insights into the Parathyroid Hormone Market’s Growth Opportunities for 2024-2033

    Key Insights into the Parathyroid Hormone Market’s Growth Opportunities for 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Estimated Growth Rate for the Parathyroid Hormone Market Between 2024 and 2033?

    In the past few years, the parathyroid hormone market has witnessed a consistent growth. There is a projected increase from $2.35 billion to $2.43 billion between 2023 and 2024, giving a compound annual growth rate (CAGR) of 3.5%. The reasons contributing to growth during the historic period include the escalating occurrence of chronic kidney disease, enhanced awareness about parathyroid hormone related disorders, surging demand for parathyroid hormone analogs, a rise in government subsidies for research on parathyroid hormone, and rising disposable incomes.

    The market size for parathyroid hormone is predicted to sustain constant growth over the coming years, escalating to worth $3.5 billion by 2028 with a Compound Annual Growth Rate (CAGR) of 9.6%. The forecasted growth for this period is linked to factors such as the increase in the elderly population, development of private healthcare sectors, the emergence of new indications, precision medicine, heightened awareness of bone health, and broader healthcare access. Key trends anticipated during this period are advancements in parathyroid hormone testing, drug delivery developments, combination therapies, the inclusion of digital health, and sustainability and environmentally friendly approaches.

    Claim Your Free Sample of the Global Parathyroid Hormone Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3427&type=smp

    What Are the Primary Contributors to the Growth of the parathyroid hormone Market?

    The escalation in osteoporosis cases is anticipated to act as a key driver for the parathyroid hormone market growth. Osteoporosis, a medical condition characterized by diminished bone mass and bone tissue degradation, significantly elevates the probability of fractures. As per the International Osteoporosis Foundation, around 1.4 million Canadians are affected by this condition, predominantly postmenopausal women and the elderly population. The parathyroid hormone, a naturally produced hormone that regulates calcium levels, is used to mitigate the fracture risk in osteoporosis patients and is provided via a daily subcutaneous injection. Therefore, the increasing prevalence of osteoporosis is predicted to foster the expansion of the parathyroid hormone market.

    Which Key Segments Comprise the Parathyroid Hormone Market?

    1) By Disease Type: Hypocalcemia, Hypoparathyroidism

    2) By Product Type: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues

    3) By End-User: Hospitals, Clinics, Other End-Users

    What Are the Key Trends Reshaping the Parathyroid Hormone Market?

    Firms within the parathyroid hormone sector are directing their efforts towards the creation of biosimilars of parathyroid-related drugs. A biosimilar is a biologic replica of an already existing FDA-sanctioned biologic, otherwise known as the reference product. Biosimilars could potentially offer consumers a means to cut down on healthcare costs without sacrificing the quality of treatment, a reason why companies that manufacture parathyroid hormones are investing in them. For example, in January 2021, a pharmaceutical company based in the UK, Theramex, launched a product named Livogiva. Teriparatide, the only medication for osteoporosis that stimulates bone growth, is now accessible in a new format known as Livogiva. This product is a pre-filled pen, designed to simplify its usage for patients prone to osteoporosis. Livogiva is primarily recommended for postmenopausal women suffering from osteoporosis who have an increased risk of fractures.

    Order Now for Fast Delivery of Your Parathyroid Hormone Market Report!

    https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

    What Are the Top Regions Fueling Growth in the Parathyroid Hormone Market?

    North America was the largest region in the parathyroid hormone market in 2023. The Middle East is expected to be the fastest-growing region in the global parathyroid hormone market share during the forecast period. The regions covered in the parathyroid hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

    The Parathyroid Hormone Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the parathyroid hormone market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Parathyroid Hormone Market Include

    1. Parathyroid Hormone Market Executive Summary

    2. Parathyroid Hormone Market Segments

    3. Parathyroid Hormone Market Size And Template Market Growth Rate

    4. Key Parathyroid Hormone Market Trends

    5. Major Parathyroid Hormone Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Parathyroid Hormone Market

    26. Top Parathyroid Hormone Companies

    27. Parathyroid Hormone Market Opportunities And Strategies

    28. Parathyroid Hormone Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Hormonal Contraceptives Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

    Drugs For Hormonal Replacement Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

    Thyroid Cancer Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Top 5 Insights From The Parathyroid Hormone Market Report 2024

    Top 5 Insights From The Parathyroid Hormone Market Report 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Parathyroid Hormone Global Market Report 2024, the parathyroid hormone market is expected to show promising growth in the forecast period.

    Introduction: A Steady Rise in Market Size

    The parathyroid hormone market has experienced steady growth in recent years, with its size projected to increase from $2.35 billion in 2023 to $2.43 billion in 2024, reflecting a compound annual growth rate (CAGR) of 3.5%. This growth is attributed to various factors driving demand and innovation in parathyroid hormone-related treatments.

    Elevated Prevalence Of Osteoporosis Sparks Growth In The Parathyroid Hormone Market

    • Osteoporosis prevalence rises, fueling demand for parathyroid hormone-based treatments.
    • Parathyroid hormone helps reduce fracture risk in osteoporosis patients.
    • Major companies in the market include Pfizer Inc., Eli Lilly and Company, and Novartis AG.

    Biosimilar Development In The Parathyroid Hormone Market Enhances Affordability And Treatment Standards

    • Companies focus on developing biosimilars of parathyroid-based drugs to enhance affordability.
    • Biosimilars offer reduced healthcare costs without compromising treatment standards.
    • Theramex launched Livogiva, a novel form of teriparatide, for osteoporosis treatment.

    View More On The Parathyroid Hormone Market Report 2024 – https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

    Takeda’s Strategic Acquisition Of Shire PLC Fuels Global Expansion

    • Takeda Pharmaceutical Company Limited acquires Shire Plc for $46 billion.
    • The acquisition expands Takeda’s scale and geographical footprint.
    • Shire Plc specializes in innovative and rare disease drugs, including natpara, a parathyroid hormone product.

    Segmentation Insights and Regional Trends

    1. Disease Type:
      • Hypocalcemia
      • Hypoparathyroidism
    2. Product Type:
      • Recombinant Parathyroid Hormone
      • Parathyroid Hormone Analogues
    3. End-User:
      • Hospitals
      • Clinics
      • Other End-Users

    Regional Dynamics: Insights into Market Share

    • North America dominated the parathyroid hormone market in 2023.
    • The Middle East is poised to exhibit the fastest-growing region in the global market share during the forecast period.

    Future Outlook: Embracing Transformative Trends

    • The forecast period anticipates advances in parathyroid hormone testing and drug delivery.
    • Combination therapies and digital health integration are expected to shape future treatment landscapes.
    • Sustainability and green initiatives are likely to influence product development and manufacturing processes.

    Conclusion: Navigating Towards Growth and Innovation

    The parathyroid hormone market presents promising opportunities for growth and innovation. With the rising prevalence of osteoporosis and increasing investments in biosimilar development, the market is poised for expansion. Strategic acquisitions and partnerships, such as Takeda’s acquisition of Shire PLC, underscore the industry’s commitment to global expansion and enhanced treatment access. As the market evolves, embracing segmentation insights and regional trends will be essential for stakeholders to navigate towards a future marked by sustained growth and improved patient outcomes.

    Request A Sample Of The Global Parathyroid Hormone Market Report 2024:

    https://www.thebusinessresearchcompany.com/sample_request?id=3427&type=smp